Japanese professor of immunology and genomic medicine (1942–)
Tasuku Honjo is a Japanese immunology researcher who discovered a key mechanism that helps the immune system recognize and attack cancer cells, work that earned him the Nobel Prize in Physiology or Medicine in 2018. His discovery has led to new cancer treatments that have helped improve outcomes for patients with various types of cancer worldwide.
AI-generated from the Wikipedia summary — may contain errors.
5 total works indexed
· 2000 · cited 4,386x
· 2000 · cited 2,878x
· 2002 · cited 2,701x
· 1992 · cited 2,635x
· 2001 · cited 2,402x
via Crossref · CC0
Tasuku Honjo (本庶 佑, Honjo Tasuku; born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.
He was elected as a foreign associate of the National Academy of Sciences of the United States (2001), as a member of German Academy of Natural Scientists Leopoldina (2003), and also as a member of the Japan Academy (2005).
via Wikidata · CC0
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).